Literature DB >> 29582391

Authors' reply: Safety of Human Papillomavirus Vaccines.

Kristine Macartney1,2, Anastasia Phillips3, Cyra Patel4, Alexis Pillsbury4, Julia Brotherton5,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29582391     DOI： 10.1007/s40264-018-0655-1

Source DB:  PubMed          Journal:  Drug Saf        ISSN： 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  26 in total

1.  Peripheral Sympathetic Nerve Dysfunction in Adolescent Japanese Girls Following Immunization with the Human Papillomavirus Vaccine.

Authors:  Sharon J B Hanley; Kevin G J Pollock; Kate Cuschieri
Journal:  Intern Med       Date:  2015-08-01       Impact factor: 1.271

2.  Proposed HPV vaccination syndrome is unsubstantiated.

Authors:  Helen Petousis-Harris
Journal:  Clin Rheumatol       Date:  2015-10-21       Impact factor: 2.980

3.  Meeting of the Global Advisory Committee on Vaccine Safety, 7–8 June 2017.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2017-07-14

Review 4.  An Overview of Quadrivalent Human Papillomavirus Vaccine Safety: 2006 to 2015.

Authors:  Michelle Vichnin; Paolo Bonanni; Nicola P Klein; Suzanne M Garland; Stan L Block; Susanne K Kjaer; Heather L Sings; Gonzalo Perez; Richard M Haupt; Alfred J Saah; Fabio Lievano; Christine Velicer; Rosybel Drury; Barbara J Kuter
Journal:  Pediatr Infect Dis J       Date:  2015-09       Impact factor: 2.129

Review 5.  Safety of Human Papillomavirus Vaccines: An Updated Review.

Authors:  Anastasia Phillips; Cyra Patel; Alexis Pillsbury; Julia Brotherton; Kristine Macartney
Journal:  Drug Saf       Date:  2018-04       Impact factor: 5.606

6.  Canadian paediatricians' approaches to managing patients with adverse events following immunization: The role of the Special Immunization Clinic network.

Authors:  Karina A Top; Joseline Zafack; Gaston De Serres; Scott A Halperin
Journal:  Paediatr Child Health       Date:  2014-06       Impact factor: 2.253

7.  Understanding the role of human variation in vaccine adverse events: the Clinical Immunization Safety Assessment Network.

Authors:  Philip S LaRussa; Kathryn M Edwards; Cornelia L Dekker; Nicola P Klein; Neal A Halsey; Colin Marchant; Roger Baxter; Renata J M Engler; Jennifer Kissner; Barbara A Slade
Journal:  Pediatrics       Date:  2011-04-18       Impact factor: 7.124

8.  Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977.

Authors:  L B Schonberger; D J Bregman; J Z Sullivan-Bolyai; R A Keenlyside; D W Ziegler; H F Retailliau; D L Eddins; J A Bryan
Journal:  Am J Epidemiol       Date:  1979-08       Impact factor: 4.897

Review 9.  Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis.

Authors:  Mélanie Drolet; Élodie Bénard; Marie-Claude Boily; Hammad Ali; Louise Baandrup; Heidi Bauer; Simon Beddows; Jacques Brisson; Julia M L Brotherton; Teresa Cummings; Basil Donovan; Christopher K Fairley; Elaine W Flagg; Anne M Johnson; Jessica A Kahn; Kimberley Kavanagh; Susanne K Kjaer; Erich V Kliewer; Philippe Lemieux-Mellouki; Lauri Markowitz; Aminata Mboup; David Mesher; Linda Niccolai; Jeannie Oliphant; Kevin G Pollock; Kate Soldan; Pam Sonnenberg; Sepehr N Tabrizi; Clare Tanton; Marc Brisson
Journal:  Lancet Infect Dis       Date:  2015-03-03       Impact factor: 25.071

10.  Quadrivalent HPV vaccine safety review and safety monitoring plans for nine-valent HPV vaccine in the United States.

Authors:  Julianne Gee; Cindy Weinbaum; Lakshmi Sukumaran; Lauri E Markowitz
Journal:  Hum Vaccin Immunother       Date:  2016-03-30       Impact factor: 3.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.